Antibiotic resistance threatens the lives of millions and the world's economy
A new study warns that antibiotic-resistant bacteria could cause the deaths of around 10 million people annually by 2050, with global economic losses potentially reaching two trillion dollars a year. These shocking estimates came in a report from the British research center Center for Global Development, which described antimicrobial resistance (AMR) as a growing global threat.
The main reason for this crisis is the overuse of antibiotics in humans and animals, leading to the development of bacteria that are unaffected by current treatments. At the same time, medical research is suffering from a severe slowdown in the development of effective new drugs. The study indicates that countries such as the United States, China, the United Kingdom, and EU countries will be the most affected. The situation has worsened with these countries recently reducing their development aid, including programs aimed at combating antibiotic resistance in poor countries. For example, the UK has halted funding for the Fleming Fund, which supported efforts to combat resistant bacteria in low-income areas, and the United States and several European countries have significantly reduced their contributions. The study described these actions as a "self-destructive strategy."
The economic impacts will be enormous. Estimates indicate significant losses in GDP and a clear increase in resistant infections, which means more treatment costs, longer hospital stays, and increasing pressure on healthcare systems. Patient numbers are also expected to nearly double while the number of workers decreases due to illness-related absenteeism. According to the IHME Institute, antibiotic resistance deaths could rise by 60% by 2050, with projections of 1.34 million deaths annually in the United States and 184,000 in the United Kingdom due to these infections.
Despite this grim picture, the study offers a glimmer of hope. If governments invest in developing new drugs, improving treatment methods, and expanding antibiotic resistance programs, millions of lives can be saved, and the economy can be significantly supported. In the United States alone, annual economic gains could reach $150 billion, and in the United Kingdom, around $12 billion.
But to achieve this, strong international cooperation, increased awareness, and swift policy adjustments are required. Otherwise, the world may revert to an era where the simplest types of infections were a cause of death.